Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

She Sense: an accurate and non-invasive test that enables simpler, earlier and more cost-effective diagnosis of patients with endometriosis

Project description

Simple diagnosis of endometriosis

Endometriosis is a disease where tissue similar to the lining of the uterus grows outside of it, affecting millions of women of reproductive age worldwide. Diagnosis usually involves a pelvic exam, ultrasound or MRI, and, in some cases, laparoscopic examination of the abdomen. Funded by the European Innovation Council, the Endosolve project proposes to simplify and improve the diagnosis of endometriosis by introducing a newly developed digital biomarker. The test has already shown promising results in pre-clinical and exploratory human volunteer studies, but further refinement, validation in a clinical setting, and business model development are needed.

Objective

Endometriosis is a chronic inflammatory disease defined as the presence of endometrium-like tissue outside the uterus. Establishment and growth of such endometriotic tissue is estrogen-dependent, thus it is mostly found in women of reproductive age. It is estimated that currently at least 190 million women and adolescent girls worldwide are affected by the disease during reproductive age although some women may suffer beyond menopause

She Sense is an accurate and non-invasive test that enables simpler, earlier and more cost-effective diagnosis of patients with endometriosis

Project scope: Experimental proof of principle for the novel digital biomarker has been demonstrated using early generation prototypes for research purposes in a pre-clinical model and exploratory human volunteer study. Sision Medical seeks to mature this technology and validate it’s use as a clinically acceptable diagnostic test.

Therefore, the scope of this project will focus on the advancement of the She Sense test to investor readiness by;
• Further refinement of the signal processing to optimise the digital biomarker performance
• Validation of the biomarker in a clinical setting
• Development of a sustainable business case and business model towards commercialisation
The end point of the project is the compilation and evaluation of data obtained in a prospective clinical study. EIC funding will enable Sision Medical to enhance the technology efficacy and validation in a clinical setting. This will pave the path for larger studies which will demonstrate clinically acceptable sensitivity and specificity of the She Sense diagnostic test.

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-EIC-2022-TRANSITION-01

See all projects funded under this call

Coordinator

ONAWAVE MEDICAL LIMITED
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 2 499 166,00
Address
ATU IHUB GALWAY CITY, OLD DUBLIN ROAD
H91 DCH9 GALWAY
Ireland

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 2 499 166,25
My booklet 0 0